However, the predicted activation of STAT3 rather than STAT1 in the upstream analysis using Ingenuity Pathway Analysis (IPA), suggests a possible negative regulation of IFNG/STAT1 signaling, counter-balancing the inflammatory anti-tumor response. This evidence concerns the gene STAT1 and neoplasm.